Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	ZNF717 ZNF845 ZNF141 ZBTB20 ZNF695 ZNF154 ZNF493 ZNF658 ZNF337 RBBP4 ZNF180 PEG3 ZNF189 ZNF195 ZNF696 ZNF300 ZNF205 ZNF57 ZNF227 ZNF236 ZNF658B ZNF850 ZNF518A PRDM1 ZNF490 ZNF8 ZNF599 ZNF20 ZNF526 ZNF716 ZNF100 ZSCAN20 ZBED4 ZSCAN22 ZNF728 PRMT5 ZNF587 ZNF283 ZNF256 ZNF81 ZNF615 ZNF723 ZNF417 ZNF471 ZNF415 UTY ZNF443	6.64e-21	1459	132	47	GO:0000977
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	ZNF717 ZNF845 ZNF141 ZBTB20 ZNF695 ZNF154 ZNF493 ZNF658 ZNF337 ZNF180 PEG3 ZNF189 ZNF195 ZNF696 ZNF300 ZNF205 ZNF57 ZNF227 ZNF236 ZNF658B ZNF850 ZNF518A PRDM1 ZNF490 ZNF8 ZNF599 ZNF20 ZNF526 ZNF716 ZNF100 ZSCAN20 ZBED4 CSRNP3 ZSCAN22 ZNF728 ZNF587 ZNF283 ZNF256 ELF2 ZNF81 ZNF615 ZNF723 ZNF417 ZNF471 ZNF415 ZNF443	1.27e-20	1412	132	46	GO:0000981
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	ZNF717 ZNF845 ZNF141 ZBTB20 ZNF695 ZNF154 ZNF493 ZNF658 RBBP4 ZNF189 ZNF195 ZNF300 ZNF205 ZNF227 ZNF236 ZNF658B ZNF850 PRDM1 ZNF490 ZNF8 ZNF526 ZNF716 ZNF100 ZSCAN20 ZSCAN22 ZNF728 PRMT5 ZNF587 ZNF283 ZNF256 ZNF81 ZNF615 ZNF723 ZNF417 ZNF471 ZNF415 UTY	3.66e-15	1244	132	37	GO:0000978
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	ZNF717 ZNF845 ZNF141 ZBTB20 ZNF695 ZNF154 ZNF493 ZNF658 RBBP4 ZNF189 ZNF195 ZNF300 ZNF205 ZNF227 ZNF236 ZNF658B ZNF850 PRDM1 ZNF490 ZNF8 ZNF526 ZNF716 ZNF100 ZSCAN20 ZSCAN22 ZNF728 PRMT5 ZNF587 ZNF283 ZNF256 ZNF81 ZNF615 ZNF723 ZNF417 ZNF471 ZNF415 UTY	7.18e-15	1271	132	37	GO:0000987
GeneOntologyMolecularFunction	UTP diphosphatase activity	ENPP1 ASMTL	4.34e-05	2	132	2	GO:0036221
GeneOntologyMolecularFunction	lipoprotein particle binding	LIPC LPL IHH PCSK9	8.15e-05	35	132	4	GO:0071813
GeneOntologyMolecularFunction	protein-lipid complex binding	LIPC LPL IHH PCSK9	8.15e-05	35	132	4	GO:0071814
GeneOntologyMolecularFunction	benzoate-CoA ligase activity	ACSM2A ACSM2B	1.30e-04	3	132	2	GO:0018858
GeneOntologyMolecularFunction	histone H2A kinase activity	RPS6KA5 BUB1	1.30e-04	3	132	2	GO:0140995
GeneOntologyMolecularFunction	decanoate-CoA ligase activity	ACSM2A ACSM2B	2.58e-04	4	132	2	GO:0102391
GeneOntologyMolecularFunction	apolipoprotein binding	LIPC LPL PCSK9	2.96e-04	20	132	3	GO:0034185
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	ZNF717 ZNF845 ZNF695 ZNF493 ZNF658 ZNF300 ZNF227 ZNF658B ZNF850 ZBED4 CSRNP3 ZNF615	3.46e-04	560	132	12	GO:0001228
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	ZNF717 ZNF845 ZNF695 ZNF493 ZNF658 ZNF300 ZNF227 ZNF658B ZNF850 ZBED4 CSRNP3 ZNF615	3.81e-04	566	132	12	GO:0001216
GeneOntologyMolecularFunction	very-low-density lipoprotein particle binding	IHH PCSK9	4.28e-04	5	132	2	GO:0034189
GeneOntologyMolecularFunction	histone kinase activity	RPS6KA5 BUB1 ATM	8.20e-04	28	132	3	GO:0035173
GeneOntologyMolecularFunction	fatty-acyl-CoA synthase activity	ACSM2A ACSM2B	1.18e-03	8	132	2	GO:0004321
GeneOntologyMolecularFunction	lipoprotein lipase activity	LIPC LPL	1.51e-03	9	132	2	GO:0004465
GeneOntologyMolecularFunction	odorant binding	OR5P2 OR5B2 OR8B3 OR8B2 OR5F1	1.56e-03	127	132	5	GO:0005549
GeneOntologyMolecularFunction	nucleoside triphosphate diphosphatase activity	ENPP1 ASMTL	1.89e-03	10	132	2	GO:0047429
GeneOntologyMolecularFunction	medium-chain fatty acid-CoA ligase activity	ACSM2A ACSM2B	2.29e-03	11	132	2	GO:0031956
GeneOntologyMolecularFunction	phosphatidylserine 1-acylhydrolase activity	LIPC LPL	2.74e-03	12	132	2	GO:0052739
GeneOntologyMolecularFunction	protein tyrosine kinase activity	RPS6KA5 AXL INSRR HIPK2 MUSK	2.79e-03	145	132	5	GO:0004713
MousePheno	impaired glucose tolerance	PCSK1 RPS6KB1 SIRPB1 SIRPA LEPR LPIN1 BNIP3 ALMS1 PRDX3 ADGRF5 ATM	6.01e-05	480	77	11	MP:0005293
MousePheno	increased circulating ketone body level	ZBTB20 LEPR PHKB OXCT1	6.05e-05	39	77	4	MP:0002575
MousePheno	abnormal circulating glucose level	PCSK1 ZBTB20 ZNF695 POC1A ZNF493 RPS6KB1 LEPR MEP1A LPIN1 PHKB OXCT1 ALMS1 PRDX3 EIF2B5 PTCH2 ADGRF5 ACSM2A ACSM2B	6.09e-05	1188	77	18	MP:0000188
MousePheno	ketosis	ZBTB20 LEPR PHKB OXCT1	8.92e-05	43	77	4	MP:0030970
Domain	zf-C2H2	ZNF137P ZNF845 ZNF141 ZBTB20 ZNF695 ZNF154 ZNF493 ZNF658 ZNF337 ZNF180 PEG3 ZNF189 ZNF195 ZNF696 ZNF300 ZNF205 ZNF57 ZNF227 ZNF236 ZNF850 ZNF518A PRDM1 ZNF490 ZNF8 ZNF599 ZNF20 ZNF526 ZNF716 ZNF100 ZSCAN20 ZSCAN22 ZNF728 ZNF587 ZNF283 ZNF256 ZNF81 ZNF615 ZNF417 ZNF471 ZNF415 ZNF443	5.16e-27	693	131	41	PF00096
Domain	ZINC_FINGER_C2H2_2	ZNF137P ZNF845 ZNF141 ZBTB20 ZNF695 ZNF154 ZNF493 ZNF658 ZNF337 ZNF180 PEG3 ZNF189 ZNF195 ZNF696 ZNF300 ZNF205 ZNF57 ZNF227 ZNF236 ZNF850 ZNF518A PRDM1 ZNF490 ZNF8 ZNF599 ZC3H7A ZNF20 ZNF526 ZNF716 ZNF100 ZSCAN20 ZSCAN22 ZNF728 ZNF587 ZNF283 ZNF256 ZNF81 ZNF615 ZNF417 ZNF471 ZNF415 ZNF443	3.39e-26	775	131	42	PS50157
Domain	ZINC_FINGER_C2H2_1	ZNF137P ZNF845 ZNF141 ZBTB20 ZNF695 ZNF154 ZNF493 ZNF658 ZNF337 ZNF180 PEG3 ZNF189 ZNF195 ZNF696 ZNF300 ZNF205 ZNF57 ZNF227 ZNF236 ZNF850 ZNF518A PRDM1 ZNF490 ZNF8 ZNF599 ZC3H7A ZNF20 ZNF526 ZNF716 ZNF100 ZSCAN20 ZSCAN22 ZNF728 ZNF587 ZNF283 ZNF256 ZNF81 ZNF615 ZNF417 ZNF471 ZNF415 ZNF443	3.76e-26	777	131	42	PS00028
Domain	Znf_C2H2/integrase_DNA-bd	ZNF845 ZNF141 ZBTB20 ZNF695 ZNF154 ZNF493 ZNF658 ZNF337 ZNF180 PEG3 ZNF189 ZNF195 ZNF696 ZNF300 ZNF205 ZNF57 ZNF227 ZNF236 ZNF850 ZNF518A PRDM1 ZNF490 ZNF8 ZNF599 ZNF20 ZNF526 ZNF716 ZNF100 ZSCAN20 ZSCAN22 ZNF728 ZNF587 ZNF283 ZNF256 ZNF81 ZNF615 ZNF417 ZNF471 ZNF415 ZNF443	6.75e-26	694	131	40	IPR013087
Domain	Znf_C2H2	ZNF137P ZNF845 ZNF141 ZBTB20 ZNF695 ZNF154 ZNF493 ZNF658 ZNF337 ZNF180 PEG3 ZNF189 ZNF195 ZNF696 ZNF300 ZNF205 ZNF57 ZNF227 ZNF236 ZNF850 ZNF518A PRDM1 ZNF490 ZNF8 ZNF599 ZC3H7A ZNF20 ZNF526 ZNF716 ZNF100 ZSCAN20 ZSCAN22 ZNF728 ZNF587 ZNF283 ZNF256 ZNF81 ZNF615 ZNF417 ZNF471 ZNF415 ZNF443	1.51e-25	805	131	42	IPR007087
Domain	ZnF_C2H2	ZNF137P ZNF845 ZNF141 ZBTB20 ZNF695 ZNF154 ZNF493 ZNF658 ZNF337 ZNF180 PEG3 ZNF189 ZNF195 ZNF696 ZNF300 ZNF205 ZNF57 ZNF227 ZNF236 ZNF850 ZNF518A PRDM1 ZNF490 ZNF8 ZNF599 ZC3H7A ZNF20 ZNF526 ZNF716 ZNF100 ZSCAN20 ZSCAN22 ZNF728 ZNF587 ZNF283 ZNF256 ZNF81 ZNF615 ZNF417 ZNF471 ZNF415 ZNF443	1.75e-25	808	131	42	SM00355
Domain	-	ZNF845 ZNF141 ZBTB20 ZNF695 ZNF154 ZNF493 ZNF658 ZNF337 ZNF180 PEG3 ZNF189 ZNF195 ZNF696 ZNF300 ZNF205 ZNF57 ZNF227 ZNF236 ZNF850 PRDM1 ZNF490 ZNF8 ZNF599 ZNF20 ZNF526 ZNF716 ZNF100 ZSCAN20 ZSCAN22 ZNF728 ZNF587 ZNF283 ZNF256 ZNF81 ZNF615 ZNF417 ZNF471 ZNF415 ZNF443	3.61e-25	679	131	39	3.30.160.60
Domain	Znf_C2H2-like	ZNF845 ZNF141 ZBTB20 ZNF695 ZNF154 ZNF493 ZNF658 ZNF337 ZNF180 PEG3 ZNF189 ZNF195 ZNF696 ZNF300 ZNF205 ZNF57 ZNF227 ZNF236 ZNF850 ZNF518A PRDM1 ZNF490 ZNF8 ZNF599 ZC3H7A ZNF20 ZNF526 ZNF716 ZNF100 ZSCAN20 ZSCAN22 ZNF728 ZNF587 ZNF283 ZNF256 ZNF81 ZNF615 ZNF417 ZNF471 ZNF415 ZNF443	1.07e-24	796	131	41	IPR015880
Domain	KRAB	ZNF845 ZNF141 ZNF695 ZNF154 ZNF658 ZNF337 ZNF180 ZNF189 ZNF195 ZNF300 ZNF205 ZNF57 ZNF227 ZNF850 ZNF490 ZNF8 ZNF599 ZNF20 ZNF716 ZNF100 ZSCAN20 ZNF728 ZNF587 ZNF283 ZNF256 ZNF81 ZNF615 ZNF417 ZNF471 ZNF443	1.28e-23	369	131	30	SM00349
Domain	KRAB	ZNF845 ZNF141 ZNF695 ZNF154 ZNF658 ZNF337 ZNF180 ZNF189 ZNF195 ZNF300 ZNF205 ZNF57 ZNF227 ZNF850 ZNF490 ZNF8 ZNF599 ZNF20 ZNF716 ZNF100 ZSCAN20 ZNF728 ZNF587 ZNF283 ZNF256 ZNF81 ZNF615 ZNF417 ZNF471 ZNF443	1.38e-23	370	131	30	IPR001909
Domain	KRAB	ZNF845 ZNF141 ZNF695 ZNF154 ZNF658 ZNF337 ZNF180 ZNF189 ZNF195 ZNF300 ZNF205 ZNF57 ZNF227 ZNF850 ZNF490 ZNF8 ZNF599 ZNF20 ZNF716 ZNF100 ZNF728 ZNF587 ZNF283 ZNF256 ZNF81 ZNF615 ZNF417 ZNF471 ZNF443	8.58e-23	358	131	29	PS50805
Domain	KRAB	ZNF845 ZNF141 ZNF695 ZNF154 ZNF658 ZNF337 ZNF180 ZNF189 ZNF195 ZNF300 ZNF205 ZNF57 ZNF227 ZNF850 ZNF490 ZNF8 ZNF599 ZNF20 ZNF716 ZNF100 ZNF728 ZNF587 ZNF283 ZNF256 ZNF81 ZNF615 ZNF417 ZNF471 ZNF443	8.58e-23	358	131	29	PF01352
Domain	zf-C2H2_6	ZNF845 ZNF141 ZNF695 ZNF154 ZNF493 ZNF658 PEG3 ZNF195 ZNF227 ZNF236 ZNF850 PRDM1 ZNF490 ZNF8 ZNF20 ZNF526 ZNF100 ZSCAN22 ZNF728 ZNF587 ZNF283 ZNF256 ZNF615 ZNF417 ZNF443	1.61e-19	314	131	25	PF13912
Domain	AGC-kinase_C	RPS6KA5 RPS6KB1 MAST4 MASTL	6.40e-04	56	131	4	IPR000961
Domain	AGC_KINASE_CTER	RPS6KA5 RPS6KB1 MAST4 MASTL	6.40e-04	56	131	4	PS51285
Domain	S_TK_X	RPS6KA5 RPS6KB1 MAST4 MASTL	6.40e-04	56	131	4	SM00133
Domain	Retrov_capsid_C	PEG3 ADAMTS10 ZSCAN20 ZSCAN22	7.81e-04	59	131	4	IPR008916
Domain	Hirudin/antistatin	ZFAND4 ADGRF5	1.00e-03	7	131	2	IPR011061
Domain	BBOX	TRIM4 TRIM6 TRIM27 TRIM5	1.40e-03	69	131	4	SM00336
Domain	Butyrophylin	TRIM4 TRIM6 TRIM27 TRIM5	1.48e-03	70	131	4	IPR003879
Domain	-	TRIM4 TRIM6 TRIM27 TRIM5	1.56e-03	71	131	4	4.10.45.10
Domain	zf-B_box	TRIM4 TRIM6 TRIM27 TRIM5	1.64e-03	72	131	4	PF00643
Domain	GPS	ADGRB3 ADGRF5 ADGRL3	1.72e-03	34	131	3	SM00303
Domain	GPCR_2_secretin-like_CS	ADGRB3 ADGRF5 ADGRL3	1.72e-03	34	131	3	IPR017983
Domain	GPS	ADGRB3 ADGRF5 ADGRL3	1.87e-03	35	131	3	PF01825
Domain	GPS	ADGRB3 ADGRF5 ADGRL3	2.03e-03	36	131	3	PS50221
Domain	Peptidase_S8_subtilisin-rel	PCSK1 PCSK9	2.12e-03	10	131	2	IPR015500
Domain	Lipase/vitellogenin	LIPC LPL	2.12e-03	10	131	2	IPR013818
Domain	TAG_lipase	LIPC LPL	2.12e-03	10	131	2	IPR000734
Domain	Lipase_LIPH	LIPC LPL	2.12e-03	10	131	2	IPR016272
Domain	Lipase	LIPC LPL	2.12e-03	10	131	2	PF00151
Domain	Lipase_N	LIPC LPL	2.12e-03	10	131	2	IPR033906
Domain	SUBTILASE_ASP	PCSK1 PCSK9	2.12e-03	10	131	2	PS00136
Domain	SUBTILASE_HIS	PCSK1 PCSK9	2.12e-03	10	131	2	PS00137
Domain	SUBTILASE_SER	PCSK1 PCSK9	2.12e-03	10	131	2	PS00138
Domain	GPS	ADGRB3 ADGRF5 ADGRL3	2.20e-03	37	131	3	IPR000203
Domain	ZF_BBOX	TRIM4 TRIM6 TRIM27 TRIM5	2.42e-03	80	131	4	PS50119
Domain	Znf_B-box	TRIM4 TRIM6 TRIM27 TRIM5	2.53e-03	81	131	4	IPR000315
Domain	-	PCSK1 PCSK9	2.58e-03	11	131	2	3.40.50.200
Domain	Peptidase_S8/S53_dom	PCSK1 PCSK9	2.58e-03	11	131	2	IPR000209
Domain	GAIN_dom_N	ADGRB3 ADGRL3	2.58e-03	11	131	2	IPR032471
Domain	ZnF_BED	ZBED4 ZNF415	2.58e-03	11	131	2	SM00614
Domain	Peptidase_S8	PCSK1 PCSK9	2.58e-03	11	131	2	PF00082
Domain	GAIN	ADGRB3 ADGRL3	2.58e-03	11	131	2	PF16489
Domain	G_PROTEIN_RECEP_F2_1	ADGRB3 ADGRF5 ADGRL3	2.76e-03	40	131	3	PS00649
Domain	GPCR_2_extracellular_dom	ADGRB3 ADGRF5 ADGRL3	2.76e-03	40	131	3	IPR001879
Domain	G_PROTEIN_RECEP_F2_3	ADGRB3 ADGRF5 ADGRL3	2.76e-03	40	131	3	PS50227
Domain	Znf_BED	ZBED4 ZNF415	3.08e-03	12	131	2	IPR003656
Domain	SPRY	TRIM4 TRIM6 TRIM27 TRIM5	3.28e-03	87	131	4	SM00449
Domain	Unchr_dom_Cys-rich	KCP FCGBP	3.62e-03	13	131	2	IPR014853
Domain	C8	KCP FCGBP	3.62e-03	13	131	2	SM00832
Domain	TIL_dom	KCP FCGBP	4.20e-03	14	131	2	IPR002919
Domain	SPRY	TRIM4 TRIM6 TRIM27 TRIM5	4.33e-03	94	131	4	PF00622
Domain	SPRY_dom	TRIM4 TRIM6 TRIM27 TRIM5	4.33e-03	94	131	4	IPR003877
Domain	B30.2/SPRY	TRIM4 TRIM6 TRIM27 TRIM5	4.50e-03	95	131	4	IPR001870
Domain	B302_SPRY	TRIM4 TRIM6 TRIM27 TRIM5	4.50e-03	95	131	4	PS50188
Domain	Kinase-like_dom	RPS6KA5 AXL RPS6KB1 INSRR HIPK2 MAST4 BUB1 MASTL ATM MUSK	4.90e-03	542	131	10	IPR011009
Domain	PROTEIN_KINASE_ATP	RPS6KA5 AXL RPS6KB1 INSRR HIPK2 MAST4 BUB1 MASTL MUSK	5.10e-03	459	131	9	PS00107
Domain	G_PROTEIN_RECEP_F2_2	ADGRB3 ADGRF5 ADGRL3	5.20e-03	50	131	3	PS00650
Domain	7tm_2	ADGRB3 ADGRF5 ADGRL3	5.20e-03	50	131	3	PF00002
Domain	VWD	KCP FCGBP	5.49e-03	16	131	2	SM00216
Domain	VWF_type-D	KCP FCGBP	5.49e-03	16	131	2	IPR001846
Domain	VWFD	KCP FCGBP	5.49e-03	16	131	2	PS51233
Domain	VWD	KCP FCGBP	5.49e-03	16	131	2	PF00094
Domain	Propept_inh	PCSK1 PCSK9	6.20e-03	17	131	2	IPR009020
Domain	AMP-bd_C	ACSM2A ACSM2B	6.20e-03	17	131	2	IPR025110
Domain	AMP-binding_C	ACSM2A ACSM2B	6.20e-03	17	131	2	PF13193
Domain	C1-set	SIRPB1 SIRPA IGLC3	6.44e-03	54	131	3	PF07654
Domain	LH2	LIPC LPL	6.94e-03	18	131	2	SM00308
Pathway	REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION	ZNF717 ZNF141 ZNF154 ZNF493 ZNF658 ZNF337 RBBP4 ZNF180 ZNF189 ZNF195 HIPK2 ZNF696 ZNF300 ZNF205 ZNF227 PRDM1 ZNF490 ZNF599 ZNF20 ZNF716 ZNF100 PRMT5 ZNF587 ZNF256 ELF2 ZNF615 ATM IHH ZNF417 ZNF471 ZNF415 ZNF443	4.41e-10	1387	98	32	M734
Pubmed	Acetylation-Mimic Mutation of TRIM28-Lys304 to Gln Attenuates the Interaction with KRAB-Zinc-Finger Proteins and Affects Gene Expression in Leukemic K562 Cells.	ZNF845 ZNF493 ZNF195 ZNF57 ZNF227 ZNF490 ZNF8 ZNF20 ZNF100 ZNF728 ZNF587 ZNF615 ZNF417	4.45e-13	181	138	13	37372979
Pubmed	Unique features of TRIM5alpha among closely related human TRIM family members.	TRIM4 TRIM6 TRIM27 TRIM5	8.23e-09	7	138	4	17156811
Pubmed	Determinants of the higher order association of the restriction factor TRIM5alpha and other tripartite motif (TRIM) proteins.	TRIM4 TRIM6 TRIM5	2.44e-07	4	138	3	21680743
Pubmed	Candidate gene association resource (CARe): design, methods, and proof of concept.	LIPC LPL PCSK9	6.08e-07	5	138	3	20400780
Pubmed	Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition.	ZBTB20 RPS6KA5 AXL RPS6KB1 INSRR RCBTB2 PRDM1 ZBED4 RCBTB1 MUSK	2.55e-06	372	138	10	22939624
Pubmed	Polymorphisms associated with cholesterol and risk of cardiovascular events.	LIPC LPL PCSK9	5.05e-06	9	138	3	18354102
Pubmed	A gene score of nine LDL and HDL regulating genes is associated with fluvastatin-induced cholesterol changes in women.	LIPC LPL PCSK9	5.05e-06	9	138	3	19773416
Pubmed	Regulator of sex-limitation (Rsl) encodes a pair of KRAB zinc-finger genes that control sexually dimorphic liver gene expression.	ZNF695 ZNF493 ZNF195 ZNF716	5.22e-06	29	138	4	14563677
Pubmed	Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients.	LEPR LIPC LPL PCSK9 ACSM2B	6.73e-06	66	138	5	20679960
Pubmed	Concordance of two multiple analytical approaches demonstrate that interaction between BMI and ADIPOQ haplotypes is a determinant of LDL cholesterol in a general French population.	ENPP1 LIPC PCSK9	7.19e-06	10	138	3	20186155
Pubmed	Mutations in the Cacnl1a4 calcium channel gene are associated with seizures, cerebellar degeneration, and ataxia in tottering and leaner mutant mice.	PEG3 PHKB LPL	7.19e-06	10	138	3	9060410
Pubmed	Identifying genetic susceptibilities to diabetes-related complications among individuals at low risk of complications: An application of tree-structured survival analysis.	PCSK1 LIPC LPL	7.19e-06	10	138	3	16928730
Pubmed	Diagnostic value of post-heparin lipase testing in detecting common genetic variants in the LPL and LIPC genes.	LIPC LPL	1.56e-05	2	138	2	19367320
Pubmed	Mutations revealed by sequencing the 5' half of the gene for ataxia telangiectasia.	ATM NPAT	1.56e-05	2	138	2	8789452
Pubmed	Epigenome-wide three-way interaction study identifies a complex pattern between TRIM27, KIAA0226, and smoking associated with overall survival of early-stage NSCLC.	TRIM27 RUBCN	1.56e-05	2	138	2	34932879
Pubmed	The Q121 PC-1 variant and obesity have additive and independent effects in causing insulin resistance.	PCSK1 ENPP1	1.56e-05	2	138	2	11739459
Pubmed	Lipoprotein lipase 1595 c/g and hepatic lipase -480 c/t polymorphisms--impact on lipid profile in incident dialysis patients.	LIPC LPL	1.56e-05	2	138	2	19052449
Pubmed	PC-1 amino acid variant (K121Q) has no impact on progression of diabetic nephropathy in type 1 diabetic patients.	PCSK1 ENPP1	1.56e-05	2	138	2	12147787
Pubmed	Ataxia-telangiectasia locus: sequence analysis of 184 kb of human genomic DNA containing the entire ATM gene.	ATM NPAT	1.56e-05	2	138	2	9199932
Pubmed	Comparative analyses of disease risk genes belonging to the acyl-CoA synthetase medium-chain (ACSM) family in human liver and cell lines.	ACSM2A ACSM2B	1.56e-05	2	138	2	19634011
Pubmed	Peroxiredoxin 3 is a key molecule regulating adipocyte oxidative stress, mitochondrial biogenesis, and adipokine expression.	LEPR PRDX3	1.56e-05	2	138	2	21902452
Pubmed	Interaction effect of Serine447Stop variant of the lipoprotein lipase gene and C-514T variant of the hepatic lipase gene on serum triglyceride levels in young adults: the Bogalusa Heart Study.	LIPC LPL	1.56e-05	2	138	2	14564687
Pubmed	Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes.	BRCA2 ATM	1.56e-05	2	138	2	37126020
Pubmed	Lipoprotein lipase and hepatic lipase: their relationship with HDL subspecies Lp(A-I) and Lp(A-I,A-II).	LIPC LPL	1.56e-05	2	138	2	12777470
Pubmed	An Elf2-like transcription factor acts as repressor of the mouse ecto-5'-nucleotidase gene expression in hepatic myofibroblasts.	NT5E ELF2	1.56e-05	2	138	2	28667437
Pubmed	The L513S polymorphism in medium-chain acyl-CoA synthetase 2 (MACS2) is associated with risk factors of the metabolic syndrome in a Caucasian study population.	ACSM2A ACSM2B	1.56e-05	2	138	2	16521160
Pubmed	The association of the K121Q polymorphism of the plasma cell glycoprotein-1 gene with type 2 diabetes and hypertension depends on size at birth.	PCSK1 ENPP1	1.56e-05	2	138	2	15126519
Pubmed	The extent of ossification of posterior longitudinal ligament of the spine associated with nucleotide pyrophosphatase gene and leptin receptor gene polymorphisms.	ENPP1 LEPR	1.56e-05	2	138	2	15834329
Pubmed	Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.	LEPR MEP1A	1.56e-05	2	138	2	15942051
Pubmed	Human hepatic and lipoprotein lipase: the loop covering the catalytic site mediates lipase substrate specificity.	LIPC LPL	1.56e-05	2	138	2	7592706
Pubmed	High-density lipoprotein subpopulation profiles in lipoprotein lipase and hepatic lipase deficiency.	LIPC LPL	1.56e-05	2	138	2	27573733
Pubmed	Extreme Response to High-dose Testosterone in BRCA2- and ATM-mutated Prostate Cancer.	BRCA2 ATM	1.56e-05	2	138	2	27692705
Pubmed	Hepatic lipase C-514T polymorphism and its association with high-density lipoprotein cholesterol level in Tehran.	LIPC LPL	1.56e-05	2	138	2	16449872
Pubmed	Association between pathogenic germline mutations in BRCA2 and ATM and tumor-infiltrating lymphocytes in primary prostate cancer.	BRCA2 ATM	1.56e-05	2	138	2	34533610
Pubmed	BRCA2 is ubiquitinated in vivo and interacts with USP11, a deubiquitinating enzyme that exhibits prosurvival function in the cellular response to DNA damage.	USP11 BRCA2	1.56e-05	2	138	2	15314155
Pubmed	Expression of CLLD7 and CHC1L Proteins in Oral Epithelial Dysplasia in a Group of Thai Patients.	RCBTB2 RCBTB1	1.56e-05	2	138	2	38679985
Pubmed	Analyses of the genetic diversity and protein expression variation of the acyl: CoA medium-chain ligases, ACSM2A and ACSM2B.	ACSM2A ACSM2B	1.56e-05	2	138	2	29948332
Pubmed	Association of HDL-related loci with age-related macular degeneration and plasma lutein and zeaxanthin: the Alienor study.	LIPC LPL	1.56e-05	2	138	2	24223199
Pubmed	Signal regulatory protein-beta1: a microglial modulator of phagocytosis in Alzheimer's disease.	ZBTB20 SIRPB1	1.56e-05	2	138	2	19893026
Pubmed	Defective lysosomal clearance of autophagosomes and its clinical implications in nonalcoholic steatohepatitis.	LEPR ALMS1	1.56e-05	2	138	2	28842428
Pubmed	Human genes involved in lipolysis of plasma lipoproteins: mapping of loci for lipoprotein lipase to 8p22 and hepatic lipase to 15q21.	LIPC LPL	1.56e-05	2	138	2	3692485
Pubmed	Comparison of the effect of post-heparin and pre-heparin lipoprotein lipase and hepatic triglyceride lipase on remnant lipoprotein metabolism.	LIPC LPL	1.56e-05	2	138	2	25239670
Pubmed	Human POGZ modulates dissociation of HP1alpha from mitotic chromosome arms through Aurora B activation.	RBBP4 ZNF195 ZNF227 ZNF518A ZNF8	2.07e-05	83	138	5	20562864
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	ZBTB20 ZNF180 PEG3 ZNF195 ZNF300 ZNF205 ZNF236 PRDM1 ZNF716 ZSCAN20 ZBED4 ELF2 UTY	2.14e-05	808	138	13	20412781
Pubmed	The tripartite motif family identifies cell compartments.	TRIM4 TRIM6 TRIM27 TRIM5	2.14e-05	41	138	4	11331580
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	RBBP4 USP11 ZNF180 HIPK2 C15orf39 ZC3H7A ALMS1 BRCA2 PRDX3 BUB1 POLK	2.44e-05	588	138	11	38580884
Pubmed	Joint effects of common genetic variants from multiple genes and pathways on the risk of premature coronary artery disease.	LIPC LPL PCSK9	3.30e-05	16	138	3	20691829
Pubmed	Rapid and efficient cloning of cDNAs encoding Krüppel-like zinc finger proteins by degenerate PCR.	ZNF695 ZNF493 ZNF300 ZNF850	4.38e-05	49	138	4	9630514
Pubmed	SIRPα maintains macrophage homeostasis by interacting with PTK2B kinase in Mycobacterium tuberculosis infection and through autophagy and necroptosis.	SIRPB1 SIRPA	4.68e-05	3	138	2	36202053
Pubmed	Src homology 2 domain-containing protein tyrosine phosphatase substrate 1 regulates the migration of Langerhans cells from the epidermis to draining lymph nodes.	SIRPB1 SIRPA	4.68e-05	3	138	2	15034021
Pubmed	BRCA2 is required for neurogenesis and suppression of medulloblastoma.	BRCA2 ATM	4.68e-05	3	138	2	17476307
Pubmed	Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study.	BRCA2 ATM	4.68e-05	3	138	2	15084244
Pubmed	Imaging of Glioblastoma Tumor-Associated Myeloid Cells Using Nanobodies Targeting Signal Regulatory Protein Alpha.	SIRPB1 SIRPA	4.68e-05	3	138	2	34917090
Pubmed	Inhibitory regulation of osteoclast bone resorption by signal regulatory protein alpha.	SIRPB1 SIRPA	4.68e-05	3	138	2	19667119
Pubmed	Expression of BLIMP1/PRMT5 and concurrent histone H2A/H4 arginine 3 dimethylation in fetal germ cells, CIS/IGCNU and germ cell tumors.	PRDM1 PRMT5	4.68e-05	3	138	2	18992153
Pubmed	SIRPA-Inhibited, Marrow-Derived Macrophages Engorge, Accumulate, and Differentiate in Antibody-Targeted Regression of Solid Tumors.	SIRPB1 SIRPA	4.68e-05	3	138	2	28669759
Pubmed	Critical role for protein tyrosine phosphatase SHP-1 in controlling infection of central nervous system glia and demyelination by Theiler's murine encephalomyelitis virus.	SIRPB1 SIRPA	4.68e-05	3	138	2	12134038
Pubmed	Central nervous system antigen P84 can serve as a substrate for neurite outgrowth.	SIRPB1 SIRPA	4.68e-05	3	138	2	2303162
Pubmed	Mutations in ATM, NBN and BRCA2 predispose to aggressive prostate cancer in Poland.	BRCA2 ATM	4.68e-05	3	138	2	32875559
Pubmed	SHPS-1 promotes the survival of circulating erythrocytes through inhibition of phagocytosis by splenic macrophages.	SIRPB1 SIRPA	4.68e-05	3	138	2	16141346
Pubmed	A role for SHPS-1/SIRPalpha in Concanavalin A-dependent production of MMP-9.	SIRPB1 SIRPA	4.68e-05	3	138	2	17825046
Pubmed	SIRPα deficiency accelerates the pathologic process in models of Parkinson disease.	SIRPB1 SIRPA	4.68e-05	3	138	2	31322787
Pubmed	The Rho kinase pathway regulates the migration of dendritic cells through SIRP-α.	SIRPB1 SIRPA	4.68e-05	3	138	2	22391241
Pubmed	The role of PC-1 and ACE genes in diabetic nephropathy in type 1 diabetic patients: evidence for a polygenic control of kidney disease progression.	PCSK1 ENPP1	4.68e-05	3	138	2	12147786
Pubmed	Expression of recipient CD47 on rat insulinoma cell xenografts prevents macrophage-mediated rejection through SIRPα inhibitory signaling in mice.	SIRPB1 SIRPA	4.68e-05	3	138	2	23472187
Pubmed	A mammalian homolog of Drosophila tumorous imaginal discs, Tid1, mediates agrin signaling at the neuromuscular junction.	DNAJA3 MUSK	4.68e-05	3	138	2	19038220
Pubmed	SIRP/CD47 signaling in neurological disorders.	SIRPB1 SIRPA	4.68e-05	3	138	2	25795378
Pubmed	Deficiency in SIRP-α cytoplasmic recruitment confers protection from acute kidney injury.	SIRPB1 SIRPA	4.68e-05	3	138	2	31370677
Pubmed	Induced lipase mutations in the mouse.	LIPC LPL	4.68e-05	3	138	2	9918035
Pubmed	A functional subset of CD8+ T cells during chronic exhaustion is defined by SIRPα expression.	SIRPB1 SIRPA	4.68e-05	3	138	2	30770827
Pubmed	Signal regulatory protein α protects podocytes through promoting autophagic activity.	SIRPB1 SIRPA	4.68e-05	3	138	2	30888336
Pubmed	Comparative analyses of lipoprotein lipase, hepatic lipase, and endothelial lipase, and their binding properties with known inhibitors.	LIPC LPL	4.68e-05	3	138	2	23991054
Pubmed	Podocyte SIRPα reduction aggravates lupus nephritis via promoting T cell inflammatory responses.	SIRPB1 SIRPA	4.68e-05	3	138	2	38758648
Pubmed	Requirement of SIRPα for protective immunity against Leishmania major.	SIRPB1 SIRPA	4.68e-05	3	138	2	20854790
Pubmed	Impaired phosphorylation and mis-localization of Bub1 and BubR1 are responsible for the defective mitotic checkpoint function in Brca2-mutant thymic lymphomas.	BRCA2 BUB1	4.68e-05	3	138	2	14646599
Pubmed	Polymorphisms in LPL, CETP, and HL protect HIV-infected patients from atherogenic dyslipidemia in an allele-dose-dependent manner.	LIPC LPL	4.68e-05	3	138	2	26101956
Pubmed	BIT, an immune antigen receptor-like molecule in the brain.	SIRPB1 SIRPA	4.68e-05	3	138	2	9271230
Pubmed	Gene structure of mouse BIT/SHPS-1.	SIRPB1 SIRPA	4.68e-05	3	138	2	10585853
Pubmed	Two novel mutations and functional analyses of the CETP and LIPC genes underlying severe hyperalphalipoproteinemia.	LIPC LPL	4.68e-05	3	138	2	19428034
Pubmed	BRCA2, ATM, and CDK12 Defects Differentially Shape Prostate Tumor Driver Genomics and Clinical Aggression.	BRCA2 ATM	4.68e-05	3	138	2	33414135
Pubmed	ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriers.	RPS6KB1 BRCA2	4.68e-05	3	138	2	15236312
Pubmed	Genetic variants of NPAT-ATM and AURKA are associated with an early adverse reaction in the gastrointestinal tract of patients with cervical cancer treated with pelvic radiation therapy.	ATM NPAT	4.68e-05	3	138	2	21050672
Pubmed	Expression of Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 in pancreatic beta-Cells and its role in promotion of insulin secretion and protection against diabetes.	SIRPB1 SIRPA	4.68e-05	3	138	2	18635660
Pubmed	Screening for ATM sequence alterations in African-American women diagnosed with breast cancer.	BRCA2 ATM	4.68e-05	3	138	2	17333338
Pubmed	Physical activity modifies the effect of LPL, LIPC, and CETP polymorphisms on HDL-C levels and the risk of myocardial infarction in women of European ancestry.	LIPC LPL	4.68e-05	3	138	2	21252145
Pubmed	The BTB-ZF transcription factor Zbtb20 is driven by Irf4 to promote plasma cell differentiation and longevity.	ZBTB20 PRDM1	4.68e-05	3	138	2	24711583
Pubmed	PCSK9 Contributes to the Cholesterol, Glucose, and Insulin2 Homeostasis in Seminiferous Tubules and Maintenance of Immunotolerance in Testis.	LEPR PCSK9	4.68e-05	3	138	2	35586340
Pubmed	Resistance to collagen-induced arthritis in SHPS-1 mutant mice.	SIRPB1 SIRPA	4.68e-05	3	138	2	18455510
Pubmed	Signal regulatory protein alpha (SIRPalpha)/CD47 interaction and function.	SIRPB1 SIRPA	4.68e-05	3	138	2	19223164
Pubmed	Higher order lipase gene association with plasma triglycerides.	LIPC LPL	4.68e-05	3	138	2	15961789
Pubmed	Resistance exercise decreases eIF2Bepsilon phosphorylation and potentiates the feeding-induced stimulation of p70S6K1 and rpS6 in young men.	RPS6KB1 EIF2B5	4.68e-05	3	138	2	18565837
Pubmed	Endothelial SIRPα signaling controls VE-cadherin endocytosis for thymic homing of progenitor cells.	SIRPB1 SIRPA	4.68e-05	3	138	2	35511221
Pubmed	ACE and PC-1 gene polymorphisms in normoalbuminuric Type 1 diabetic patients: a 10-year prospective study.	PCSK1 ENPP1	4.68e-05	3	138	2	12126783
Pubmed	Focal cerebral ischemia upregulates SHP-1 in reactive astrocytes in juvenile mice.	SIRPB1 SIRPA	4.68e-05	3	138	2	12742627
Pubmed	Dendritic cell SIRPα regulates homeostasis of dendritic cells in lymphoid organs.	SIRPB1 SIRPA	4.68e-05	3	138	2	25818708
Pubmed	Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia.	BRCA2 ATM	4.68e-05	3	138	2	16574953
Pubmed	Role of SN1 lipases on plasma lipids in metabolic syndrome and obesity.	LIPC LPL	4.68e-05	3	138	2	24458708
Pubmed	Family-based association studies of lipid gene polymorphisms in coronary artery disease.	LIPC LPL	4.68e-05	3	138	2	15979432
Pubmed	Non-Hematopoietic and Hematopoietic SIRPα Signaling Differently Regulates Murine B Cell Maturation in Bone Marrow and Spleen.	SIRPB1 SIRPA	4.68e-05	3	138	2	26222253
Pubmed	Is olaparib cost effective in metastatic castration-resistant prostate cancer patients with at least one favorable gene mutation in BRCA1, BRCA2 or ATM?	BRCA2 ATM	4.68e-05	3	138	2	34517749
Interaction	TRIM28 interactions	ZNF845 ZNF695 ZNF493 ZNF658 RBBP4 USP11 ZNF195 ZNF57 ZNF227 TRIM6 ZNF518A ZNF490 ZNF8 ZNF20 ZNF100 OXCT1 BRCA2 ZNF728 ZNF587 ZNF256 ZNF81 ZNF615 ATM ZNF417 ZNF471 ZNF443	3.43e-06	1474	133	26	int:TRIM28
Cytoband	Ensembl 112 genes in cytogenetic band chr19q13	ZNF137P ZNF845 ZNF154 AXL ZNF180 PEG3 ZNF227 ZNF850 ZNF8 ZNF599 CLIP3 ZNF526 FCGBP ZSCAN22 ZNF587 ZNF283 ZNF256 ZNF615 ZNF417 ZNF471 ZNF415	8.12e-11	1192	138	21	chr19q13
Cytoband	19q13.43	ZNF8 ZSCAN22 ZNF587 ZNF256 ZNF417 ZNF471	2.73e-07	87	138	6	19q13.43
Cytoband	11q22-q23	ATM NPAT	1.33e-04	6	138	2	11q22-q23
Cytoband	19p12	ZNF493 ZNF100 ZNF728 ZNF723	1.63e-04	90	138	4	19p12
Cytoband	Ensembl 112 genes in cytogenetic band chr19p12	ZNF493 ZNF100 ZNF728 ZNF723	5.22e-04	122	138	4	chr19p12
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF717 ZNF845 ZNF141 ZBTB20 ZNF695 ZNF154 ZNF493 ZNF658 ZNF337 ZNF180 PEG3 ZNF189 ZNF195 ZNF696 ZNF300 ZNF205 ZNF57 ZNF227 ZNF236 ZNF850 ZNF518A PRDM1 ZNF490 ZNF8 ZNF599 ZNF20 ZNF526 ZNF716 ZNF100 ZSCAN20 ZSCAN22 ZNF728 ZNF587 ZNF283 ZNF256 ZNF81 ZNF615 ZNF417 ZNF471 ZNF415 ZNF443	1.04e-29	718	108	41	28
GeneFamily	CD molecules\|V-set domain containing\|C1-set domain containing\|Signal regulatory proteins	SIRPB1 SIRPA	3.49e-04	5	108	2	747
GeneFamily	Proprotein convertase subtilisin/kexin family	PCSK1 PCSK9	1.24e-03	9	108	2	973
GeneFamily	Receptor Tyrosine Kinases\|CD molecules	AXL INSRR MUSK	1.74e-03	40	108	3	321
GeneFamily	Ring finger proteins\|Tripartite motif containing\|ARF GTPase family	TRIM4 TRIM6 TRIM27 TRIM5	2.53e-03	95	108	4	59
Coexpression	BROWNE_HCMV_INFECTION_30MIN_DN	AXL ZNF205 SIRPA DMXL1 ALMS1 BRCA2 RUBCN MUSK	8.37e-07	145	134	8	M0
Coexpression	ZWANG_DOWN_BY_2ND_EGF_PULSE	ZNF717 ZNF493 ZNF658 ADGRB3 ZNF526 ZSCAN22 ZNF587 ZNF283 POC5 INVS	6.30e-06	321	134	10	M2615
ToppCell	368C-Myeloid-Macrophage-SPP1+_Macrophage_3\|368C / Donor, Lineage, Cell class and subclass (all cells)	ZNF845 KCP ZNF696 SIRPB1 SIRPA ALMS1 LPL ZNF81	8.78e-08	178	138	8	536a601abcc60867949ea06e9aafb6c7b799b56b
ToppCell	droplet-Kidney-nan-18m-Epithelial-Epcam____proximal_tube_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NT5E ALDH8A1 MEP1A LPL ATP11A PZP ACSM2B	8.85e-07	166	138	7	8ab18c9d911eb3a9970bba7a769294b0927538f7
ToppCell	facs-Kidney-nan-3m-Epithelial-epithelial_cell_of_proximal_tubule\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ALDH8A1 MEP1A LPIN1 LPL ATP11A PZP ACSM2B	9.98e-07	169	138	7	ee27bcfe3f9a295ec5fb0a375d77d1050e5cbaad
ToppCell	facs-Kidney-nan-3m-Epithelial-epithelial_cell_of_proximal_tubule\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ALDH8A1 MEP1A LPIN1 LPL ATP11A PZP ACSM2B	9.98e-07	169	138	7	922086f218135b734b7d370b871923e50141edce
ToppCell	368C-Myeloid-Macrophage-SPP1+_Macrophage_3\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ZNF845 ZNF493 KCP ZNF696 ALMS1 LPL ZNF81	1.41e-06	178	138	7	9d575902d3dbe33437c9d4200df093a741269803
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAST4 TMEM38A ANKRD28 ADGRF5 ATP11A POC5 UTY	1.47e-06	179	138	7	025d414ec88d5680d99c8173e70ee3bb0b694f74
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZBTB20 AXL PRDM1 MAST4 IGLC3 PZP ARHGEF26	1.96e-06	187	138	7	cfdc1585c80d2bb475d9145395fb50a88c53f838
ToppCell	mild-low-quality_cells\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ZBTB20 ALDH8A1 HELB ADAMTS10 LPIN1 ATM PZP	2.77e-06	197	138	7	e4331969bd911d1ebb5453f40a7057297b5389b4
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	OR5B2 PRDM1 LPIN1 BRCA2 IGLC3 ATM	1.15e-05	162	138	6	8ed9149ff53b285591354057055d072b203a47c8
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	OR5B2 PRDM1 LPIN1 BRCA2 IGLC3 ATM	1.15e-05	162	138	6	7a05b05a33e1309fb5c0a8171db105ae68491815
ToppCell	facs-Kidney-nan-24m-Epithelial-epithelial_cell_of_proximal_tubule\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ALDH8A1 MEP1A LPL ATP11A PZP ACSM2B	1.28e-05	165	138	6	906321cb5f299d77436fb5540fd8c52d7532beca
ToppCell	facs-Kidney-nan-24m-Epithelial-epithelial_cell_of_proximal_tubule\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ALDH8A1 MEP1A LPL ATP11A PZP ACSM2B	1.28e-05	165	138	6	02a09d0918b103aca21c36b42c5a8a8ebad8686c
ToppCell	facs-Kidney-nan-24m-Epithelial\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ALDH8A1 MEP1A LPL ATP11A PZP ACSM2B	1.32e-05	166	138	6	fe87b444fc0ef6fc20c646c9d2c3c8ce916a70c0
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ENPP1 ZNF518A ZNF20 ZNF526 BUB1 ZNF256	1.32e-05	166	138	6	c8fd241088de27c6e741a5dfee3cd770183b6bcb
ToppCell	droplet-Kidney-nan-18m-Epithelial-epithelial_cell_of_proximal_tubule\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ALDH8A1 MEP1A LPL ATP11A PZP ACSM2B	1.42e-05	168	138	6	dd48da83c32d41a62f80cd7e5e5c64e42776fa27
ToppCell	PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	POC1A AXL SIRPA LPL BUB1 MASTL	1.73e-05	174	138	6	65147b0f8c2ccadd5685430d31081520c157536a
ToppCell	368C-Myeloid-Macrophage-SPP1+_Macrophage_3\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	ZNF845 ZNF493 KCP ZNF696 ALMS1 ZNF81	1.90e-05	177	138	6	eb0cfe8e9a91910f9979608ed47add48d98ce4dd
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZBTB20 AXL TRDC PRDM1 MAST4 PZP	3.01e-05	192	138	6	97c312c82ec025c13052f8d424b11c0034c8ea54
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZBTB20 ENPP1 FAM135B LIPC ACSM2A ACSM2B	3.19e-05	194	138	6	70185c0b8e0f4e896645b17a243482ba3cdf4a5d
ToppCell	moderate-Epithelial-FOXN4+\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	POC1A NT5E ALMS1 BRCA2 BUB1 ANKRD28	3.19e-05	194	138	6	dff3fb10372053951d41e0ccd41aac3ece6009bd
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PEG3 INSRR TTC3 FMN2 UTY PCSK9	3.28e-05	195	138	6	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PEG3 INSRR TTC3 FMN2 UTY PCSK9	3.28e-05	195	138	6	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	COPD-Endothelial-VE_Capillary_B\|Endothelial / Disease state, Lineage and Cell class	HIPK2 LEPR PRDM1 MAST4 LPL ADGRF5	3.47e-05	197	138	6	30dbc05ea66892d2e18ff375ffa86d1db7bc4083
ToppCell	Sepsis-ICU-SEP-Lymphocyte-T/NK-dn_T\|ICU-SEP / Disease, condition lineage and cell class	OXCT1 MAST4 TMEM38A MASTL ANKRD28 ZNF81	3.78e-05	200	138	6	9ee3e18dc429b9c472e3e366d9bfdbb150daa369
ToppCell	mild-CD8+_T_naive\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ZBTB20 NT5E DOCK9 TTC3 HELB ATM	3.78e-05	200	138	6	c825320599a61a4c629d736f5c0fd6f1f405540a
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	TRDC ADAMTS10 RCBTB1 PZP ZNF443	4.41e-05	125	138	5	e112787b05d8147093357c9861877f6620b9e271
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	TRDC ADAMTS10 RCBTB1 PZP ZNF443	4.41e-05	125	138	5	34d5be868c9728cc4f9ce0d65acf0e50171d2587
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-Z\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	RPS6KA5 LEPR ZNF283 ATM CCDC144A	6.36e-05	135	138	5	9f9d0787a2e99207a9caa88a85565189ab8b940a
ToppCell	E18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_B\|E18.5-samps / Age Group, Lineage, Cell class and subclass	NT5E TRDC LPIN1 ZNF526 ALMS1	6.82e-05	137	138	5	b553958e7e6dcd887d860e34d3983cbb85cefaa6
Disease	total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement	LIPC LPL POC5 POLK MUSK	2.63e-06	51	126	5	EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928
Disease	free cholesterol to total lipids in small HDL percentage	TRIM5 LIPC POLK MUSK PCSK9	2.63e-06	51	126	5	EFO_0022285
Disease	free cholesterol to total lipids in large HDL percentage	TRIM5 LIPC LPL MUSK PCSK9	4.21e-06	56	126	5	EFO_0022279
Disease	free cholesterol in very large HDL measurement	LIPC LPL POC5 MUSK PCSK9	6.98e-06	62	126	5	EFO_0022273
Disease	total lipids in very large HDL measurement	LIPC LPL POC5 MUSK PCSK9	9.51e-06	66	126	5	EFO_0022312
Disease	total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer	LIPC LPL POC5 POLK MUSK	1.18e-05	69	126	5	EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992
Disease	cholesterol in very large HDL measurement	LIPC LPL POC5 MUSK PCSK9	1.18e-05	69	126	5	EFO_0022229
Disease	1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0) measurement	LIPC MUSK PCSK9	1.63e-05	12	126	3	EFO_0800466
Disease	level of tyrosine-protein phosphatase non-receptor type substrate 1 in blood serum	SIRPB1 SIRPA	1.81e-05	2	126	2	OBA_2040362
Disease	X-21319 measurement	ACSM2A ACSM2B	1.81e-05	2	126	2	EFO_0800807
Disease	phospholipid measurement	LEPR LIPC LPL POLK MUSK PCSK9	3.16e-05	140	126	6	EFO_0004639
Disease	free cholesterol in very small VLDL measurement	TRIM5 LIPC LPL PCSK9	4.90e-05	47	126	4	EFO_0022275
Disease	Lipidemias	LEPR LIPC LPL	4.95e-05	17	126	3	C1706412
Disease	Hyperlipidemia	LEPR LIPC LPL	4.95e-05	17	126	3	C0020473
Disease	X-11478 measurement	ACSM2A ACSM2B	5.41e-05	3	126	2	EFO_0021242
Disease	Hypercholesterolemia, Familial	LIPC LPL PCSK9	5.92e-05	18	126	3	C0020445
Disease	triglycerides to total lipids in medium LDL percentage	LIPC LPL POLK PCSK9	6.27e-05	50	126	4	EFO_0022334
Disease	triglycerides to total lipids in large LDL percentage	LIPC LPL POLK PCSK9	6.78e-05	51	126	4	EFO_0022331
Disease	phospholipids in very small VLDL measurement	TRIM5 LIPC LPL PCSK9	6.78e-05	51	126	4	EFO_0022300
Disease	type 2 diabetes mellitus (implicated_via_orthology)	PCSK1 RPS6KB1 INSRR LEPR ALMS1	9.00e-05	105	126	5	DOID:9352 (implicated_via_orthology)
Disease	cholesterol to total lipids in large LDL percentage	LIPC LPL POLK PCSK9	9.80e-05	56	126	4	EFO_0022235
Disease	Monogenic Non-Syndromic Obesity, Autosomal Recessive	PCSK1 LEPR	1.08e-04	4	126	2	cv:CN043636
Disease	low density lipoprotein particle size measurement	LIPC LPL POLK PCSK9	1.13e-04	58	126	4	EFO_0008593
Disease	alkaline phosphatase measurement	ZBTB20 RPS6KA5 ZNF337 KCP TRIM6 ZFAND4 LEPR TRIM5 PHKB LIPC CSRNP3 LPL FMN2 MUSK	1.15e-04	1015	126	14	EFO_0004533
Disease	cholesterol to total lipids in IDL percentage	LIPC LPL POLK PCSK9	1.28e-04	60	126	4	EFO_0022233
Disease	low density lipoprotein cholesterol measurement, lipid measurement	LEPR LIPC BRCA2 LPL PCSK9	1.33e-04	114	126	5	EFO_0004529, EFO_0004611
Disease	cholesteryl esters to total lipids in medium VLDL percentage	LIPC LPL POLK PCSK9	1.65e-04	64	126	4	EFO_0022253
Disease	hyperinsulinism (implicated_via_orthology)	LEPR LIPC	1.79e-04	5	126	2	DOID:2018 (implicated_via_orthology)
Disease	3-hydroxyhexanoate measurement	ACSM2A ACSM2B	1.79e-04	5	126	2	EFO_0800378
Disease	phospholipids in very large HDL measurement	LIPC LPL POC5 MUSK	1.86e-04	66	126	4	EFO_0022298
Disease	cholesterol to total lipids in small LDL percentage	LIPC LPL PCSK9	2.06e-04	27	126	3	EFO_0022241
Disease	cholesterol to total lipids in medium LDL percentage	LIPC LPL PCSK9	2.06e-04	27	126	3	EFO_0022238
Disease	cholesteryl ester measurement, low density lipoprotein cholesterol measurement	LEPR LIPC BRCA2 LPL PCSK9	2.12e-04	126	126	5	EFO_0004611, EFO_0010351
Disease	esterified cholesterol measurement	LEPR LIPC LPL MUSK PCSK9	2.28e-04	128	126	5	EFO_0008589
Disease	choline measurement	LEPR LIPC LPL POLK PCSK9	2.45e-04	130	126	5	EFO_0010116
Disease	familial combined hyperlipidemia (is_implicated_in)	LIPC LPL	2.68e-04	6	126	2	DOID:13809 (is_implicated_in)
Disease	indoleacetoylcarnitine measurement	ACSM2A ACSM2B	2.68e-04	6	126	2	EFO_0800106
Disease	MEDULLOBLASTOMA	BRCA2 PTCH2	2.68e-04	6	126	2	155255
Disease	1-oleoyl-2-docosahexaenoyl-GPE (18:1/22:6) measurement	LIPC MUSK	2.68e-04	6	126	2	EFO_0800471
Disease	1-palmitoyl-2-dihomo-linolenoyl-GPE (16:0/20:3) measurement	LIPC MUSK	2.68e-04	6	126	2	EFO_0800444
Disease	Medulloblastoma	BRCA2 PTCH2	2.68e-04	6	126	2	cv:C0025149
Disease	triacylglycerol 54:3 measurement	LIPC LPL MUSK	3.13e-04	31	126	3	EFO_0010421
Disease	obesity (implicated_via_orthology)	PCSK1 LEPR LPIN1 LIPC ALMS1 LPL	3.32e-04	215	126	6	DOID:9970 (implicated_via_orthology)
Disease	free cholesterol in large HDL measurement	LIPC LPL POC5 MUSK	3.72e-04	79	126	4	EFO_0022157
Disease	level of Phosphatidylcholine (18:2_20:3) in blood serum	LIPC MUSK	3.75e-04	7	126	2	OBA_2045108
Disease	1-oleoyl-2-arachidonoyl-GPE (18:1/20:4) measurement	LIPC MUSK	3.75e-04	7	126	2	EFO_0800470
Disease	1-oleoyl-2-linoleoyl-GPE (18:1/18:2) measurement	LIPC MUSK	3.75e-04	7	126	2	EFO_0800443
Disease	infertility (implicated_via_orthology)	BRCA2 ATM	3.75e-04	7	126	2	DOID:5223 (implicated_via_orthology)
Disease	level of Phosphatidylcholine (17:0_18:2) in blood serum	LIPC MUSK	3.75e-04	7	126	2	OBA_2045086
Disease	cholesteryl ester measurement, high density lipoprotein cholesterol measurement	LEPR TRIM5 LIPC LPL POC5 MUSK PCSK9	3.99e-04	312	126	7	EFO_0004612, EFO_0010351
Disease	free cholesterol measurement, high density lipoprotein cholesterol measurement	LEPR TRIM5 LIPC LPL POC5 MUSK PCSK9	4.22e-04	315	126	7	EFO_0004612, EFO_0008591
Disease	phospholipids:total lipids ratio	TRIM5 LIPC LPL POC5 MUSK PCSK9	4.43e-04	227	126	6	EFO_0020946
Disease	phospholipid measurement, high density lipoprotein cholesterol measurement	LEPR TRIM5 LIPC LPL POC5 MUSK PCSK9	4.72e-04	321	126	7	EFO_0004612, EFO_0004639
Disease	lipoprotein measurement, phospholipid measurement	LEPR LIPC POLK PCSK9	4.91e-04	85	126	4	EFO_0004639, EFO_0004732
Disease	2-arachidonoyl-GPE (20:4) measurement	LIPC MUSK	4.98e-04	8	126	2	EFO_0800260
Disease	hydroxypalmitoyl sphingomyelin (d18:1/16:0(OH)) measurement	MUSK PCSK9	4.98e-04	8	126	2	EFO_0800583
Disease	free cholesterol:total lipids ratio, intermediate density lipoprotein measurement	LIPC LPL MUSK PCSK9	5.14e-04	86	126	4	EFO_0008595, EFO_0020945
Disease	free cholesterol to total lipids in large VLDL percentage	LIPC LPL PCSK9	5.31e-04	37	126	3	EFO_0022281
Disease	lipid measurement, high density lipoprotein cholesterol measurement	LEPR TRIM5 LIPC LPL POC5 MUSK PCSK9	5.57e-04	330	126	7	EFO_0004529, EFO_0004612
Disease	triglyceride measurement, C-reactive protein measurement	LEPR LPL MUSK	5.75e-04	38	126	3	EFO_0004458, EFO_0004530
Disease	triglycerides to total lipids in large VLDL percentage	LIPC LPL PCSK9	6.21e-04	39	126	3	EFO_0022332
Disease	Hypercholesterolemia	LIPC LPL PCSK9	6.21e-04	39	126	3	C0020443
Disease	1-arachidonoyl-GPE (20:4n6) measurement	LIPC MUSK	6.39e-04	9	126	2	EFO_0800248
Disease	Glioma	BRCA2 PTCH2	6.39e-04	9	126	2	cv:C0017638
Disease	1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4) measurement	LIPC MUSK	6.39e-04	9	126	2	EFO_0800409
Disease	1-stearoyl-2-arachidonoyl-GPE (18:0/20:4) measurement	LIPC MUSK	6.39e-04	9	126	2	EFO_0800403
Disease	alcohol dependence (implicated_via_orthology)	RPS6KB1 INSRR	6.39e-04	9	126	2	DOID:0050741 (implicated_via_orthology)
Disease	signal-regulatory protein beta-1 measurement	SIRPB1 SIRPA	6.39e-04	9	126	2	EFO_0802069
Disease	1-palmitoyl-2-linoleoyl-GPE (16:0/18:2) measurement	LIPC MUSK	6.39e-04	9	126	2	EFO_0800272
Disease	cholesterol in very small VLDL measurement	TRIM5 LIPC PCSK9	6.69e-04	40	126	3	EFO_0022231
Disease	triglyceride measurement, low density lipoprotein cholesterol measurement	LIPC BRCA2 LPL MUSK PCSK9	7.49e-04	166	126	5	EFO_0004530, EFO_0004611
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	LIPC LPL MUSK	7.73e-04	42	126	3	EFO_0008317, EFO_0008596, EFO_0020945
Disease	medulloblastoma (is_implicated_in)	BRCA2 PTCH2	7.96e-04	10	126	2	DOID:0050902 (is_implicated_in)
Disease	1-palmitoyl-2-oleoyl-GPE (16:0/18:1) measurement	LIPC MUSK	7.96e-04	10	126	2	EFO_0800608
Disease	1-stearoyl-2-linoleoyl-GPE (18:0/18:2) measurement	LIPC MUSK	7.96e-04	10	126	2	EFO_0800402
Disease	cholesteryl ester 22:5 measurement	LIPC MUSK	7.96e-04	10	126	2	EFO_0021444
Disease	triacylglycerol 56:6 measurement	FCGBP LPL MUSK	8.28e-04	43	126	3	EFO_0010433
Disease	free cholesterol to total lipids in IDL percentage	LIPC LPL MUSK	8.28e-04	43	126	3	EFO_0022278
Disease	free cholesterol to total lipids in very small VLDL percentage	LIPC LPL PCSK9	8.28e-04	43	126	3	EFO_0022290
Disease	cholesteryl ester measurement	TRIM5 LIPC LPL POC5 MUSK PCSK9	8.49e-04	257	126	6	EFO_0010351
Disease	type 2 diabetes mellitus (is_implicated_in)	AXL ENPP1 LEPR LIPC LPL	8.56e-04	171	126	5	DOID:9352 (is_implicated_in)
Disease	Thromboembolism	TRIM6 TRIM5 FAM135B	8.86e-04	44	126	3	HP_0001907
Disease	total lipids in very small VLDL measurement	LIPC LPL PCSK9	9.46e-04	45	126	3	EFO_0022156
Disease	cholesterol to total lipids in large VLDL percentage	LIPC LPL PCSK9	9.46e-04	45	126	3	EFO_0022236
Disease	1-stearoyl-2-oleoyl-GPE (18:0/18:1) measurement	LIPC MUSK	9.70e-04	11	126	2	EFO_0800269
Disease	Malignant neoplasm of pancreas	AXL BRCA2 BUB1 ATM	9.75e-04	102	126	4	C0346647
Disease	triacylglycerol 54:4 measurement	LIPC LPL MUSK	1.01e-03	46	126	3	EFO_0010422
Disease	sleep duration, triglyceride measurement	LIPC LPL MUSK ACSM2B	1.05e-03	104	126	4	EFO_0004530, EFO_0005271
Disease	Gastrointestinal Stromal Sarcoma	HIPK2 PTCH2 IHH	1.07e-03	47	126	3	C3179349
Disease	free cholesterol in small VLDL measurement	LIPC LPL PCSK9	1.07e-03	47	126	3	EFO_0022272
Disease	end stage renal disease (biomarker_via_orthology)	LPIN1 BNIP3 LPL	1.07e-03	47	126	3	DOID:783 (biomarker_via_orthology)
Disease	lipoprotein measurement	LEPR LIPC LPL POC5	1.09e-03	105	126	4	EFO_0004732
Disease	level of Phosphatidylinositol (18:0_20:3) in blood serum	LIPC MUSK	1.16e-03	12	126	2	OBA_2045157
Disease	familial hyperlipidemia (implicated_via_orthology)	LIPC LPL	1.16e-03	12	126	2	DOID:1168 (implicated_via_orthology)
Disease	level of Phosphatidylcholine (16:0_20:2) in blood serum	LIPC MUSK	1.16e-03	12	126	2	OBA_2045074
Disease	apolipoprotein B to apolipoprotein A1 ratio	TRIM5 LPL PCSK9	1.21e-03	49	126	3	EFO_0021897
Disease	linoleic acid measurement	LIPC MAST4 LPL MUSK PCSK9	1.24e-03	186	126	5	EFO_0006807
Disease	Medulloblastoma	BRCA2 PTCH2 ATM	1.29e-03	50	126	3	C0025149
Disease	Gastrointestinal Stromal Tumors	HIPK2 PTCH2 IHH	1.29e-03	50	126	3	C0238198
Disease	cholesteryl esters to total lipids in IDL percentage	LIPC LPL PCSK9	1.29e-03	50	126	3	EFO_0022247

Protein segments in the cluster

Peptide	Gene	Start	Entry
FFASSSLHHTSECTQ	ALDH8A1	116	Q9H2A2
TNHCDLGDTSSYHTK	AGAP9	226	Q5VTM2
GCETHKVANTSSFHT	BUB1	426	O43683
HNKSICTTTTAFLHF	ADGRB3	936	O60242
ASTTHHCVETGSQEA	ACSM2A	201	Q08AH3
SHTFISSVESECHSS	MASTL	306	Q96GX5
KTHTTCSCNHLTNFA	ADGRL3	831	Q9HAR2
FTTSITFSSHRHSKC	ALMS1	2711	Q8TCU4
TFSSHRHSKCISNSS	ALMS1	2716	Q8TCU4
NTALHLACSKGHETS	ANKRD28	891	O15084
HHLFSNITDVCEASK	ARHGEF26	481	Q96DR7
SGSQEHVCQSSSKLH	CCDC144CP	331	Q8IYA2
NSLVHAFTCHDSGAT	DMXL1	2876	Q9Y485
TSHTGQASHECTEAL	ADAMTS10	1031	Q9H324
ACHSAHTSAAKTQGG	RCBTB1	291	Q8NDN9
IEIAACHSTHTSAAK	RCBTB2	311	O95199
CHSTHTSAAKTQGGH	RCBTB2	316	O95199
QTCDGHKAHTSFQIS	PZP	1356	P20742
VDSSGHSVGCHAQKT	NPAT	1011	Q14207
AHTATVRSVHFCSDG	POC1A	101	Q8NBT0
CDFHISSHSKTDESS	POC5	91	Q8NA72
DFGSASHVSKAVCST	HIPK2	346	Q9H2X6
CDTHFQDSNHRTSTA	GPANK1	221	O95872
ARSVGSASVFCHVHK	KCNK15	281	Q9H427
VFTGVAIVHCSSKDH	ASMTL	121	O95671
TLKSCQIHVNGSHSD	KIAA2026	636	Q5HYC2
CYSDGTAVHESHAKN	CSRNP3	411	Q8WYN3
NFTDSTTQSCTHSRH	EIF2B5	326	Q13144
SKCDSHGTHLAGVVS	PCSK9	221	Q8NBP7
AESVATCHFNHSSKT	LPL	61	P06858
GHQKALSTCASHFTA	OR5B2	231	Q96R09
KESIHDGTVTHTFCG	RPS6KB1	241	P23443
HGFNAITQTIKCSHE	LIPC	266	P11150
ICDKSHFQAIHSESS	LPIN1	301	Q14693
GTHFSNLSKTTFHCC	LEPR	76	P48357
RTDNSESCVHGKHDS	ENPP1	861	P22413
SSGAAVHTCVKATFH	RPS6KA5	706	O75582
ASNHETAHNVICKTS	LRRC3B	161	Q96PB8
TQGRSKAFSTCSSHV	OR8B3	231	Q8NGG8
GHQKTFSTCASHLTV	OR6X1	231	Q8NH79
VCGETFLHSSSLKEH	PEG3	631	Q9GZU2
SHSVDAHTAEVNCLS	RBBP4	266	Q09028
SAEGKHQAFSTCSAH	OR10A4	231	Q9H209
STEGHHKAFSTCTSH	OR5P2	226	Q8WZ92
HKAFSTCTSHLTVVT	OR5P2	231	Q8WZ92
HCTSVSKEVEGTSYH	ATM	2111	Q13315
QHESGRSSSKSSHCD	BNIP3	51	Q12983
TFFHVSCDNSSKGST	DOCK9	731	Q9BZ29
HKSVSSANTCGIFST	BRCA2	1966	P51587
NEISTLSTSCSHFQH	GJA9	331	P57773
AVLSGHSCAQKHTTC	FCGBP	221	Q9Y6R7
SHKSYSCQVTHEGST	IGLC3	81	P0DOY3
SGSQEHVCQSSSKLH	CCDC144B	381	Q3MJ40
ITGTNHHSEKEFCSY	PRMT5	266	O14744
EASVHSSNAHCTDKT	ELF2	81	Q15723
HFLSKHFCTTESIAT	MAST4	326	O15021
NHAAHTVGCSAATFV	INSRR	791	P14616
QTESSSLHSACVHDS	FAM135B	51	Q49AJ0
SGSQEHVCQSSSKFH	CCDC144A	381	A2RUR9
STCSDFNHGSALHIA	CLIP3	191	Q96DZ5
HEHSVSSAFKNSCNI	FMN2	841	Q9NZ56
GTKHNPFICTASFHT	DNAJA3	71	Q96EY1
VSSQSFSHCFLHSTS	RUBCN	611	Q92622
TGTHSFFHCTSEGNK	SCP2D1-AS1	131	Q9BR46
DASSQSSKTNHHSCL	HELB	706	Q8NG08
VHCSVKSEHSAAAKT	IHH	186	Q14623
TTCLHSVFNVHTGDE	PHKB	146	Q93100
SHVSSLSFCDSNVIH	OR5F1	161	O95221
TQGRSKAFSTCSSHV	OR8B2	231	Q96RD0
TAREHSKGQSACVHF	INVS	691	Q9Y283
QGDADSHLSCHTATS	UTY	641	O14607
NVTERCHTFTFSHAT	TRIM27	451	P14373
LAKDCHSGDFSVHVT	KCP	1241	Q6ZWJ8
QAFTHCEASSQHVVT	PTCH2	601	Q9Y6C5
TTHTLLDHCTFEKAN	MEP1A	261	Q16819
TPQHTVSFTCESHGF	SIRPA	161	P78324
NCEVVAVSVDSHFSH	PRDX3	126	P30048
HECQVCHKRFSSTSN	PRDM1	631	O75626
KGCVCSFSTSAHRHT	OXCT1	26	P55809
FNDSAVDNHSKCSHI	SIX6OS1	326	Q8N1H7
PQHTVSFTCESHGFS	SIRPB1	161	Q5TFQ8
IKFSTGSHCHGSFSL	NT5E	546	P21589
LEATVSCSGSHHIKC	ADGRF5	576	Q8IZF2
ASTTHHCVETGSQEA	ACSM2B	201	Q68CK6
HASLCDAISGSVAHS	C15orf39	771	Q6ZRI6
SSSSHCTSSIDGKHV	C10orf67	496	Q8IYJ2
CHVTTASLDGESSHK	ATP11A	176	P98196
CGKTFSQELTLTCHH	ZNF845	276	Q96IR2
GEHQICLHSNSTKFS	TMED9	116	Q9BVK6
EGVKCSAFQDSSFHT	TRIM5	406	Q9C035
QHQRFHTGKTSFACT	ZNF615	641	Q8N8J6
CGKTFSVSAHLVQHQ	ZNF189	461	O75820
ECGKAFNRSSHLTTH	ZNF100	321	Q8IYN0
NECGKTFSHSSSFTH	ZNF599	566	Q96NL3
SKESHHCGESFNQIA	ZNF20	76	P17024
ECGKAFNQSSHLTEH	ZNF695	356	Q8IW36
CGKSFSDHSNLITHQ	ZSCAN20	771	P17040
FKSSSSCEVHERTHF	ZNF490	371	Q9ULM2
ECGKSFLSSSALHVH	ZNF587	496	Q96SQ5
CGKAFSQSSHITTHK	ZNF723	346	P0DPD5
CGKSFIHSSSLITHQ	ZNF256	356	Q9Y2P7
CGKSFTHSSTLLQHQ	ZNF256	496	Q9Y2P7
FNIEHCHQNSSSTVS	POLK	736	Q9UBT6
ECGKSFLSSSALHVH	ZNF417	496	Q8TAU3
ECGKDFNQSSHLTTH	ZNF728	596	P0DKX0
SDCGKAFIHSSHVVR	ZNF696	156	Q9H7X3
DCHKVFSNATTIANH	ZNF137P	76	P52743
SSFSCEAHNAKGVTT	AXL	201	P30530
ECGKAFTFSSTLNTH	ZNF716	356	A6NP11
KSHCSTGDAHTVLSE	TTC3	1416	P53804
LNLTKHFTSTHCVNG	ZNF518A	191	Q6AHZ1
ECGSIFTTSSHFAKH	ZNF141	231	Q15928
TNSHAHTGSSDCDIS	ZBTB20	56	Q9HC78
ECAKSFCSSSHPIQH	ZNF658	416	Q5TYW1
ECGKTFSRSTHLTQH	ZSCAN22	356	P10073
TFCHKSNLSTHQGTH	ZNF717	766	Q9BY31
CGKSFSRSSHLVSHQ	ZNF180	386	Q9UJW8
STACSHPVTKHEFED	ZC3H7A	591	Q8IWR0
CDKTFTHSSSLTVHF	ZNF471	211	Q9BX82
CGKSFSHSSHLTAHQ	ZNF205	481	O95201
CGKGFSVHSSLTTHQ	ZNF415	521	Q09FC8
IDFCSFQNHKTTHTG	ZNF443	486	Q9Y2A4
AECGKSFCHSTHLTV	ZNF8	316	P17098
ECGKAFNRSSHLTTH	ZNF493	421	Q6ZR52
CSVQHDNKTVHSTDF	TRDC	71	B7Z8K6
VHTGEKCFSQSSHLR	ZNF227	271	Q86WZ6
HTGQKSHECQSYSKA	ZNF57	526	Q68EA5
THTGQKLFSCHVCSN	ZNF236	1216	Q9UL36
AHVGGTHECTTCSKV	ZNF526	326	Q8TF50
CGKSFSQNSSLIEHH	ZNF154	306	Q13106
SAVDGVHLHTFSCSS	TRIM4	461	Q9C037
AAAGKSVGECTTHHL	ZFAND4	636	Q86XD8
DLGKSHTVQFSHTDS	USP11	206	P51784
VSCKVFLTATHSHSS	TMEM38A	221	Q9H6F2
NSQSCILGTVSFHHK	ZNF300	96	Q96RE9
ECGKSFTSHSTLIQH	ZNF850	761	A8MQ14
CGKAFTQFSHLTVHE	ZNF195	611	O14628
DCSVLGSQHFSSGKH	TRIM6	341	Q9C030
HQTTHTGEKLFECSE	ZNF81	376	P51508
HQNTHTGEKSYVCSV	ZNF337	226	Q9Y3M9
FTCGSKLVHERTHSN	ZNF283	636	Q8N7M2
ECAKSFCSSSHPIQH	ZNF658B	176	Q4V348
TLNEGEHSSVQCFSH	ZBED4	816	O75132
HNVTFGSFVTLHCTA	MUSK	221	O15146
TSADLHNDCTETHTG	PCSK1	366	P29120
HNDCTETHTGTSASA	PCSK1	371	P29120